Johnson & Johnson (NYSE:JNJ) FY Conference September 10, 2025 11:30 AM ET Company ParticipantsJoaquin Duato - Chairman and CEOJohn Reed - EVP, Head of Pharma R&DConference Call ParticipantsTerence Flynn - Biopharma AnalystTerence FlynnGreat. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S. Biopharma Analyst. I'm very pleased to be hosting Johnson & Johnson this afternoon. Joining us from the company, we have Joaquin Duato, the company's Chairman and CEO, and John Reed, Executive Vi ...